Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_assertion description "[EGFR expression but not HER2 gene amplification was significantly associated with poor overall survival in patients with type II EC, (EGFR, median survival 20 vs 33 months, P=0.028; HER2, median survival 18 vs 29 months, P=0.113) and EGFR expression retained prognostic independence when adjusting for histology, stage, grade, and age (EGFR, P=0.0197; HER2, P=0.7855).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_assertion evidence source_evidence_literature NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_assertion SIO_000772 19088718 NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_assertion wasDerivedFrom befree-20140225 NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_assertion wasGeneratedBy ECO_0000203 NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP281390.RAkntHeqHbMwL1aDHO7pMtBJvuxLwwcs16FPm4BehzPbw130_provenance.